Skip to main content
. 2017 Aug 9;12:2385–2390. doi: 10.2147/COPD.S140915

Table 1.

Baseline characteristics of study participants

Non-COPD
(N=2,542)
COPD
(N=421)
P-value
Age 56.4±10.3 65.4±8.8 <0.001
Male sex 992 (39.0) 317 (75.3) <0.001
Height, cm 160.9±8.7 164.5±8.6 <0.001
BMI, kg/m2 24.3±3.1 23.9±2.8 0.01
Current smoker 344 (13.7) 111 (27.2) <0.001
Waist circumference, cm 83.5±8.9 86.1±8.3 <0.001
Hypertension 722 (28.4) 172 (40.9) <0.001
Diabetes 246 (9.7) 68 (16.2) <0.001
MI/angina 73 (3.0) 22 (5.4) 0.01
Depression 139 (5.5) 15 (3.6) 0.16
Pulmonary function test
 FVC, L 3.45±0.84 3.68±0.91 <0.001
 FVC, % predicted 93.3±11.2 91.1±14.2 0.002
 FEV1, L 2.73±0.66 2.35±0.64 <0.001
 FEV1, % predicted 94.9±11.6 79.9±15.3 <0.001
 FEV1/FVC, % 79.4±4.7 63.9±6.3 <0.001
Hand grip strength, kg 29.9±9.5 33.3±9.1 <0.001
EQ-5D index 0.94±0.11 0.92±0.13 <0.001
 Mobility 1.49±1.65 1.51±1.46 0.77
 Self-care 1.38±1.64 1.33±1.45 0.53
 Daily activity 1.43±1.64 1.39±1.45 0.64
 Pain/discomfort 1.61±1.66 1.58±1.47 0.71
 Anxiety/depression 1.46±1.65 1.38±1.46 0.36

Note: Data shown as mean ± standard deviation and n (%).

Abbreviations: BMI, body mass index; MI, myocardial infarction; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; EQ-5D, EuroQOL5-item questionnaire.